Journal of The Academy of Clinical Microbiologists

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  26 (2024)
Volume  23 (2021)
Volume  22 (2020)
Volume  21 (2019)
Volume  20 (2018)
Volume  19 (2017)
Volume  18 (2016)
Volume  17 (2015)
Volume  16 (2014)
Volume  15 (2013)
Related articles

VOLUME 19 , ISSUE 2 ( July-December, 2017 ) > List of Articles

Original Article

Oropharyngeal candidiasis among HIV seropositive patients in Chennai, South India: An evaluation of Polymerase chain reaction-Restriction Fragment Length polymorphism for speciation and Antifungal drug resistance

Abirami Lakshmy Jayachandran, Radhika Katragadda, Ravinder Thyagarajan, K Leela, K Shanmugam, Amutha Chelliah

Keywords : Antifungal susceptibility pattern, non-albicans Candida

Citation Information : Jayachandran AL, Katragadda R, Thyagarajan R, Leela K, Shanmugam K, Chelliah A. Oropharyngeal candidiasis among HIV seropositive patients in Chennai, South India: An evaluation of Polymerase chain reaction-Restriction Fragment Length polymorphism for speciation and Antifungal drug resistance. 2017; 19 (2):86-92.

DOI: 10.4103/jacm.jacm_23_16

License: CC BY-NC 4.0

Published Online: 17-08-2024

Copyright Statement:  Copyright © 2017; Wolters Kluwer India Pvt. Ltd.


Abstract

CONTEXT: Oropharyngeal candidiasis is a common opportunistic manifestation of HIV/acquired immunodeficiency syndrome. Non-albicans Candida and drug-resistant strains are on the rise leading to treatment difficulties. AIMS: The present study aims to speciate, perform antifungal susceptibility, and also to evaluate the significance of antifungal drug resistance by correlating the prior exposure to Fluconazole and CD-4 counts. SETTINGS AND DESIGN: This was a cross-sectional study. MATERIALS AND METHODS: A total of 115 HIV patients with clinical evidence of oropharyngeal candidiasis were included in the study. Two swabs were collected from the lesions. Speciation and antifungal susceptibility by microbroth dilution method for fluconazole, itraconazole, and amphotericin B were done as per the standard microbiological techniques. Polymerase chain reaction and restriction fragment length polymorphism (PCR and RFLP) were performed for speciating the Non-albicans candida. The association between prior exposure to Fluconazole, CD-4 counts, and antifungal resistance was assessed (Fisher's exact test, Chi-square test P < 0.05 was considered as statistically significant). RESULTS: Among the 115 patients, 60 (52.17%) showed culture positivity for Candida species. Candida albicans 35 (56.45%) was the predominant species isolated followed by Candida tropicalis 12 (19.30%). PCR RFLP produced specific products for 19 of the non albicans Candida. A resistance of 17 (27.41%) and 18 (29.00%) was seen to fluconazole and itraconazole, respectively. A significant association was observed between prior exposure to Fluconazole and drug resistance (P = 0.0201).The correlation between CD-4 counts and antifungal resistance was not statistically significant (P = 0.595). CONCLUSION: Antifungal susceptibility testing should be performed routinely along with species-level identification whether it is the first or recurrent episode of oral candidiasis and therapy should be modified accordingly to prevent the morbidity and mortality.

PDF Share
  1. Brito GN, Inocêncio AC, Querido SM, Jorge AO, Koga-Ito CY. In vitro antifungal susceptibility of Candida spp. Oral isolates from HIV-positive patients and control individuals. Braz Oral Res 2011;25:28-33.
  2. Enwuru CA, Ogunledun A, Idika N, Enwuru NV, Ogbonna F, Aniedobe M, et al. Fluconazole resistant oppurtunistic oesophageal Candida and non-Candida yeast like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria. Afr Health Sci 2008;8:142-8.
  3. Darouiche RO. Oropharyngeal and esophageal candidiasis in immunocompromised patients: Treatment issues. Clin Infect Dis 1998;26:259-72.
  4. Jeddy N, Ranganathan K, Devi U, Joshua E. A study of antifungal drug sensitivity of Candida isolated from human immunodeficiency virus infected patients in Chennai, South India. J Oral Maxillofac Pathol 2011;15:182-6.
  5. Agarwal S, Manchanda V, Verma N, Bhalla P. Yeast identification in routine clinical microbiology laboratory and its clinical relevance. Indian J Med Microbiol 2011;29:172-7.
  6. Baradkar VP, Kumar S. Species identification of Candida isolates obtained from oral lesions of HIV infected patients. Indian J Dermatol 2009;54:385-6.
  7. Adhikary R, Joshi S. Species distribution and anti-fungal susceptibility of candidaemia at a multi super-specialty center in Southern India. Indian J Med Microbiol 2011;29:309-11.
  8. Shokohi T, Hashemi Soteh MB, Saltanat Pouri Z, Hedayati MT, Mayahi S. Identification of Candida species using PCR-RFLP in cancer patients in Iran. Indian J Med Microbiol 2010;28:147-51.
  9. Ayatollahi Mousavi SA, Salari S, Rezaie S, Nejad NS, Hadizadeh S, Kamyabi H, et al. Identification of Candida species isolated from oral colonization in Iranian HIV-positive patients, by PCR-RFLP method. Jundishapur J Microbiol 2012;5:336-40.
  10. Vijayakumar R, Giri S, Kindo AJ. Molecular species identification of Candida from blood samples of Intensive Care Unit patients by polymerase chain reaction – Restricted fragment length polymorphism. J Lab Physicians 2012;4:1-4.
  11. Clinical and Laboratory Standards Institute (CLSI), “Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, 3rd ed.,” Wayne, Pa: USA, CLSI Document M27-A3, Clinical and Laboratory Standards Institute; 2009.
  12. Pfaller MA, Castanheira M, Diekema DJ, Messer SA, Jones RN. Triazole and echinocandin MIC distributions with epidemiological cutoff values for differentiation of wild-type strains from non-wild-type strains of six uncommon species of Candida. J Clin Microbiol 2011;49:3800-4.
  13. Samaranayake L. Commensal oral Candida in Asian cohorts. Int J Oral Sci 2009;1:2-5.
  14. Dar MS, Sreedar G, Shukla A, Gupta P, Rehan AD, George J, et al. An in vitro study of antifungal drug susceptibility of Candida species isolated from human immunodeficiency virus seropositive and human immunodeficiency virus seronegative individuals in Lucknow population Uttar Pradesh. J Oral Maxillofac Pathol 2015;19:205-11.
  15. Mane A, Panchvalli S, Bembalkar S, Risbud A. Species distribution & antifungal susceptibility of oral Candida colonising or infecting HIV infected individuals. Indian J Med Res 2010;131:836-8.
  16. Hamza OJ, Matee MI, Moshi MJ, Simon EN, Mugusi F, Mikx FH, et al. Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis. BMC Microbiol 2008;8:135.
  17. Nadagir SD, Chunchanur SK, Halesh LH, Yasmeen K, Chandrasekhar MR, Patil BS, et al. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients. Southeast Asian J Trop Med Public Health 2008;39:492-5.
  18. Badiee P, Alborzi A, Davarpanah MA, Shakiba E. Distributions and antifungal susceptibility of Candida species from mucosal sites in HIV positive patients. Arch Iran Med 2010;13:282-7.
  19. Mirhendi H, Makimura K, Khoramizadeh M, Yamaguchi H. A one-enzyme PCR-RFLP assay for identification of six medically important Candida species. Nihon Ishinkin Gakkai Zasshi 2006;47:225-9.
  20. Roshan R, Sabokbar A, Badali H. Identification of Candida species isolated from vulvovaginal candidiasis using PCR-RFLP. Int J Mol Clin Microbiol 2014;2:406-10.
  21. Coata CR, Lenos JA, Passos XS, De arabja CR. Species distribution and antifungal susceptibility profile of oral Candida isolates from HIV infected patients in the antiretroviraltherapy era. Mycopathologia 2006;162:45-50.
  22. Vargas KG, Joly S. Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals. J Clin Microbiol 2002;40:341-50.
  23. Nweze EI, Ogbonnaya UL. Oral candida isolates among HIV-infected subjects in Nigeria. J Microbiol Immunol Infect 2011;44:172-7.
  24. Mulu A, Kassu A, Anagaw B, Moges B, Gelaw A, Alemayehu M, et al. Frequent detection of ‘azole’ resistant Candida species among late presenting AIDS patients in Northwest Ethiopia. BMC Infect Dis 2013;13:82.
  25. Lattif AA, Banerjee U, Prasad R, Biswas A, Wig N, Sharma N, et al. Susceptibility pattern and molecular type of species-specific Candida in oropharyngeal lesions of Indian human immunodeficiency virus-positive patients. J Clin Microbiol 2004;42:1260-2.
  26. Dharwad S, Sadhana Dominic RM. Species identification of Candida isolates in various clinical specimens with their antifungal susceptibility patterns. J Clin Diagn Res 2011;5:1177-81.
  27. Gautam RK, Garg AP. Microbiological and clinical assessment of Candida carriage in different clinical samples from HIV-infected and non infected patients. Sch J Appl Med Sci 2013;1:69-75.
  28. Jayalakshmi L, RatnaKumari G, Samson SH. Isolation, speciation and antifungal susceptibility testing of Candida from clinical specimens at a tertiary care hospital. Sch J Appl Med Sci 2014;2:3193-8.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.